Showing 101-110 of 1827 results for "".
Early Recognition + Earlier Intervention = Slowing the Progression in Mild Cognitive Impairment / Early Alzheimer’s
https://practicalneurology.com/programs/cme/early-recognition-earlier-intervention-slowing-the-progression-in-mild-cognitive-impairment-early-alzheimers/24279/Tune in to learn about early recognition and the latest on diagnosing and treating patients with mild cognitive impairment and early Alzheimer’s.Unraveling the Impact of Environmental Factors on Sleep Quality and Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/unraveling-the-impact-of-environmental-factors-on-sleep-quality-and-parkinson-disease/32197/A review of the effects of various environmental factors—extreme temperatures, air and noise pollution, chemical exposures, and heavy metals—on both sleep and Parkinson disease.- Turf Wars: Reports From the Front Linehttps://practicalneurology.com/columns/practice-management/turf-wars-reports-from-the-front-line/31111/In the October 2007 issue of Practical Neurology, Associate Editor Zac Haughn explores the complex landscape of professional conflicts and collaborations within the field of neurology. The article delves into the "turf wars" that arise when neurologists compete with other specialists, such as pulmon
Movement Disorders Moment: Environmental and Biologic Risk and Protective Factors Associated with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-momentbrenvironmental-and-biologic-risk-and-protective-factors-associated-with-parkinson-disease/32120/This review provides a concise summary of the evidence for environmental and biologic risk and protective factors for Parkinson disease.Association of Lifestyle Factors with Cognition
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/association-of-lifestyle-factors-with-cognition/32012/Evidence supports the benefit of cognitive, social, physical, and multimodal interventions for people at different stages of cognitive and functional impairment.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31085/Managing Personality Disorders in Dementia Patients: Expert InsightsIn the December 2007 issue of *Practical Neurology*, a panel of experts discusses the complexities of treating personality disorders in dementia patients, focusing on pharmacological strategies and the implications of recent studies
Advances in Neuromodulation for Essential Tremor
https://practicalneurology.com/diseases-diagnoses/movement-disorders/advances-in-neuromodulation-for-essential-tremor/32163/Advancements in neuromodulation continue to expand treatment options for medication-refractory essential tremor.Improving Outcomes Earlier in Generalized Myasthenia Gravis: Roadmap for Incorporating Targeted Therapies Into Clinical Practice
https://practicalneurology.com/programs/cme/improving-outcomes-earlier-in-generalized-myasthenia-gravis-roadmap-for-incorporating-targeted-therapies-into-clinical-practice/29145/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Headache Horizons: The Study and Use of Psychedelics in Cluster Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-horizons-the-study-and-use-of-psychedelics-in-cluster-headache/32032/Psychedelics have a history of use in headache disorders and evidence exists for their therapeutic benefit in cluster headache.Updates in Diagnostic Testing in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/A review of diagnostic tests for Parkinson disease, including DAT-SPECT, α-synuclein skin biopsy and CSF studies, and genetic testing, offering guidance on their appropriate use and interpretation.